Article
The role of transcription factors in prostate cancer progression
10 Feb 2025
Abstract excerpt
Prostate cancer is one of the most common malignancies in men, with most cases initially responding to androgen deprivation therapy. However, a significant number of patients eventually develop castration-resistant prostate cancer, an aggressive form of the disease. Although androgen receptor (AR) pathway inhibitors target AR signaling, and have extended survival in patients with castration-resistant prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
